Our formulation scientists have many years’ experience in developing a range of oral dose formulations for early stage clinical trials. With both non GMP and GMP facilities we can provide flexible and efficient solutions to develop a fit for purpose formulation for early phase / First-in-Human supplies.
Addressing the increasing pressure for pharmaceutical companies to bring clinical candidates through their pipeline faster and with greater efficiency, we provide expert pharmaceutical development solutions.
Operating from state-of-the-art, custom designed facilities, our scientists can develop your clinical candidate into an optimum formulation, and manufacture oral dose products for all stages of clinical trials.
From developing a fit-for-purpose formulation for First-in-Human trials, to developing a more robust formulation and scaling up for late phase trials and ultimately commercialisation, our integrated pharmaceutical development solutions are customised to meet your needs.
News: Learn about our Pharmaceutical Development Expansion to Charnwood Campus here.
At Almac, we have the technical experience and knowledge to develop robust, solid oral formulations and manufacturing processes. We have assisted many of our clients in developing both immediate and modified release formulations for their late stage clinical trials, registration batch manufacture and onward to commercial launch.